Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
Título
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
Autor
C Trojaniello, M G Vitale, P A Ascierto
Fecha
2021
Identificador
10.1016/j.annonc.2021.02.008
Fuente
Annals of oncology : official journal of the European Society for Medical Oncology
Colección
Citación
C Trojaniello, M G Vitale, P A Ascierto, “Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.,” SOCICT Open, consulta 11 de junio de 2026, https://www.socictopen.socict.org/items/show/8754.
Position: 11288 (27 views)